首页|蛋白激酶mTOR调控心肌细胞衰老机制的研究进展

蛋白激酶mTOR调控心肌细胞衰老机制的研究进展

Mechanisms of Protein Kinase mTOR Regulating Cardiomyocyte Aging

扫码查看
人口老龄化导致心血管疾病的发病率持续增高,机体衰老和心肌细胞衰老常相伴而行.心肌细胞衰老的特征主要表现为氧化应激增加、细胞周期活动停滞、代谢紊乱等,其主要与细胞自噬、线粒体功能障碍、端粒缩短以及慢性炎症等途径有关.在这些导致心肌细胞衰老的途径中,常伴有蛋白激酶的异常表达和功能障碍.蛋白激酶mTOR可通过激活一系列级联反应参与衰老相关的心血管疾病的发生和发展.现就mTOR调节心肌细胞衰老的机制进行讨论并总结,提示mTOR未来可能成为预防或治疗心肌细胞衰老的重要靶点.
The aging of the population has led to a rising incidence of cardiovascular disease,and physical aging and cardiomyocyte aging often accompanies it.The cardiomyocyte aging is characterized by increased oxidative stress,cell cycle activity arrest,and metabolic disorders,which is mainly associated with molecular effects such as autophagy,mitochondrial dysfunction,telomere shortening and chronic inflammation.Among these pathways leading to cardiomyocyte aging,it is usually accompanied by abnormal expression and dysfunction of protein kinases.Particularly,mTOR can be involved in the generation and development of aging-associated cardiovascular disease through the activation of a series of cascading reactions.In this review,we focus on the mechanisms by which mTOR regulates cardiomyocyte aging,suggesting that mTOR may be an important target for preventing or treating cardiomyocyte aging in the future.

Protein kinaseMammalian target of rapamycinCardiomyocyteAgingCardiovascular disease

王思博、经鹏、杨彤彤、赵迪、王连生

展开 >

南京医科大学第一附属医院心内科,江苏南京 210029

蛋白激酶 哺乳动物雷帕霉素靶蛋白 心肌细胞 衰老 心血管疾病

国家自然科学基金面上项目

82370344

2024

心血管病学进展
成都市心血管病研究所,成都市第三人民医院

心血管病学进展

CSTPCD
影响因子:0.932
ISSN:1004-3934
年,卷(期):2024.45(5)